- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Authors
Latest:
Trust Between Patients and Clinicians: An Overlooked and Affordable Approach to Improving US Health CareRaising the visibility of the importance of trust in patient-clinician relationships can help ensure it is acknowledged and incorporated into policy and tactical considerations.
Latest:
Benefits of Continuing Subcutaneous Daratumumab After Initial Quad Therapy: Pieter Sonneveld, MD, PhDPieter Sonneveld, MD, PhD, professor of hematology and chair of the Erasmus MC Cancer Institute in Rotterdam, Netherlands, discussed the continued use of subcutaneous daratumumab following initial treatment, as well as the changing landscape of multiple myeloma treatment.
Latest:
Novel Multicancer Early Detection Technology––Potential Value to Employers and the WorkforceMulticancer early detection technology could help reduce cancer mortality compared to the current strategy of single-cancer screening tests.
Latest:
Relationship Between Medication Adherence and Other Medicare Star Rating MeasuresPerformance on Medicare Star Ratings medication adherence measures is significantly tied to performance on the intermediate outcome and statin process measures.
Latest:
Experts Recount What Aspects of SECO Will Be Vital to Their Future PracticeAttendees and experts from the Southeastern Educational Congress of Optometry (SECO) 2025 meeting highlight research and sessions they will take away.
Latest:
Covishield India: Demystifying Myths Through an Early Multicenter Safety StudyThis was a multicenter study carried out in India to study the adverse and systemic effects of the indigenously developed Covishield vaccine.
Latest:
Reimagining the Inpatient Palliative Care Consult: Lessons From COVID-19Digital innovations in palliative care during COVID-19 have changed how hospitalized patients receive palliative care. We propose an approach to implement new models at scale.
Latest:
Pricing and Insurance Networks in Outpatient Surgery MarketsThis article examines how prices, insurer payments, and patient payments for outpatient surgeries differ by site of care and network status.
Latest:
Mental Health Service Utilization Review Patterns in a Medicaid Managed Care ProgramMedicaid managed care utilization review data for mental health services were analyzed for the calendar years 2017 and 2018. These data indicate low rates of utilization review denials for both inpatient and outpatient mental health services.
Latest:
Community Health Workers’ Critical Role in Trust Building Between the Medical System and Communities of ColorThe authors interrogate elements of routine medical practice in New York City to argue for reforms of hospital culture through relational trust-building capabilities of community health workers.
Latest:
Spending Patterns Among Commercially Insured Individuals During the COVID-19 PandemicIn this analysis of more than 97 million commercially insured individuals, investigators found that the COVID-19 pandemic induced a spending shock in 2020 and that health care spending did not recover to baseline until mid-2021.
Latest:
Chronic Overlapping Pain Conditions and Long-term Opioid TreatmentLittle is known about opioid prescribing patterns in patients with chronic overlapping pain conditions. This study suggests target populations for interventions to manage chronic pain.
Latest:
Clinic Price Reductions in a Tiered Total Cost Benefit DesignFindings of this evaluation of primary care clinic responses in a tiered total cost of care benefit design suggest that clinics respond by reducing prices.
Latest:
Advancing Team-Based Primary Care: The Importance and Challenges in 2023This editorial describes several key lessons about the development of effective value-based care delivery.
Latest:
Medicare Expenditures in the First Year of Amyotrophic Lateral Sclerosis DiagnosisMedicare expenditures for patients with amyotrophic lateral sclerosis are more than 3 times those of the average Medicare beneficiary, and drug therapies are an important cost driver.
Latest:
GLP-1 Receptor Agonists: Trend, Necessity, or Blessing?Glucagon-like peptide 1 (GLP-1) receptor agonists offer promise in weight and cardiovascular risk reduction, but their use must complement—not replace—lifestyle interventions within a holistic, patient-centered care model.
Latest:
Influence of Prior Authorization Requirements on Provider Clinical Decision-MakingAn online survey identified that documentation requirements and communication issues with health plans are associated with providers modifying clinical decisions to avoid medication prior authorization.
Latest:
Glofitamab/Polatuzumab Vedotin Exhibits Response Durability in R/R LBCLThe glofitamab-based regimen displayed manageable safety, with minimal high-grade CRS and infrequent low-grade ICANS, in relapsed/refractory LBCL.
Latest:
Risk Assessments of Drug-Related Problems for Cardiac Surgery PatientsRisk assessments of drug-related problems for cardiac surgery patients can be conducted by implementing a framework for patient safety.
Latest:
Workforce Innovation Reduces Medicaid Costs in Chronic CareThis study of community health workers as clinical extenders demonstrates significant cost savings in managing chronic conditions among Medicaid beneficiaries.
Latest:
Post-SNF Outcomes and Cost Comparison: Medicare Advantage vs Traditional MedicarePatients enrolled in Medicare Advantage had better outcomes and lower cost following skilled nursing facility (SNF) discharge than patients enrolled in traditional fee-for-service Medicare.
Latest:
The Value of Virtual Physical Therapy for Musculoskeletal CareThis counterfactual simulation study on a nationally representative sample of the working population with musculoskeletal conditions estimated the value of patient-initiated virtual physical therapy.
Latest:
Development of Multipayer Claims-Based Emergency Department Episodes of CareThirty-day episodes of care initialized by emergency department visits can inform future quality improvement efforts.
Latest:
Physiologic Insulin Resensitization Lowers Cost in Patients With Diabetes and Kidney DiseasePatients with diabetes and chronic kidney disease receiving physiologic insulin resensitization had much lower annual costs of care than similar patients not receiving it.
